The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB
Open accessAbstract
The Epstein–Barr virus latent membrane protein 1 (LMP1) is essential for the transformation of B lymphocytes into lymphoblastoid cell lines. Previous data are consistent with a model that LMP1 is a constitutively activated receptor that transduces signals for transformation through its carboxyl-terminal cytoplasmic tail. One transformation effector site (TES1), located within the membrane proximal 45 residues of the cytoplasmic tail, constitutively engages tumor necrosis factor receptor-associated factors. Signals from TES1 are sufficient to drive initial proliferation of infected resting B lymphocytes, but most lymphoblastoid cells infected with a virus that does not express the 155 residues beyond TES1 fail to grow as long-term cell lines. We now find that mutating two tyrosines to an isoleucine at the carboxyl end of the cytoplasmic tail cripples the ability of EBV to cause lymphoblastoid cell outgrowth, thereby marking a second transformation effector site, TES2. A yeast two-hybrid screen identified TES2 interacting proteins, including the tumor necrosis factor receptor-associated death domain protein (TRADD). TRADD was the only protein that interacted with wild-type TES2 and not with isoleucine-mutated TES2. TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells. In transfection assays, TRADD and TES2 synergistically mediated high-level NF-κB activation. These results indicate that LMP1 appropriates TRADD to enable efficient long-term lymphoblastoid cell outgrowth. High-level NF-κB activation also appears to be a critical component of long-term outgrowth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.
Durfee, T., Becherer, K., Chen, P. L., Yeh, S. H., Yang, Y., Kilburn, A. E., Lee, W. H., & Elledge, S. J. (1993) · Genes & Development · doi:10.1101/gad.7.4.555 · Cited by 1,451
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Self-citationTNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex
Hsu, H., Huang, J., Shu, H.-B., Baichwal, V., & Goeddel, D. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80252-6 · Cited by 1,182
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Self-citationTing, A. T., Pimentel‐Muiños, F. X., & Seed, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01007.x · Cited by 550
Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Hammerschmidt, W., & Sugden, B. (1989) · Nature · doi:10.1038/340393a0 · Cited by 541
Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., & Mosialos, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7098 · Cited by 491
Self-citationEpstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen, J. I., Wang, F., Mannick, J., & Kieff, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9558 · Cited by 483
Self-citationHuen, D. S., Henderson, S. A., Croom-Carter, D. S. G., & Rowe, M. (1995) · PubMed · Cited by 457
Shu, H.-B., Takeuchi, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13973 · Cited by 423
Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35741-7 · Cited by 409
Wang, D., Liebowitz, D., Wang, F., Gregory, C. D., Rickinson, A. B., Larson, R. A., Springer, T. A., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4173-4184.1988 · Cited by 384
Self-citationEpstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation
Dawson, W. O., Rickinson, A. B., & Young, L. S. (1990) · Nature · doi:10.1038/344777a0 · Cited by 366
TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.
Cheng, G., & Baltimore, D. (1996) · Genes & Development · doi:10.1101/gad.10.8.963 · Cited by 285
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.
Baichwal, V. R., & Sugden, B. (1988) · PubMed · Cited by 275
Mitchell, T., & Sugden, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2968-2976.1995 · Cited by 273
Wilson, J. B., Weinberg, W. C., Johnson, R., Yuspa, S. H., & Levine, A. J. (1990) · Cell · doi:10.1016/0092-8674(90)90695-b · Cited by 247
CD40 and Its Ligand in Host Defense
Noelle, R. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80408-2 · Cited by 231
Kaye, K. M., Devergne, O., Harada, J. N., Izumi, K. M., Yalamanchili, R., Kieff, E., & Mosialos, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11085 · Cited by 226
Self-citationOrientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
Liebowitz, D., Wang, D., & Kieff, E. (1986) · Journal of Virology · doi:10.1128/jvi.58.1.233-237.1986 · Cited by 223
Self-citationIzumi, K. M., Kaye, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1447 · Cited by 218
Self-citationHammarskjöld, M. L., & Simurda, M. C. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6496-6501.1992 · Cited by 206
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
CD40-mediated signaling in B cells. Balancing cell survival, growth, and death
Kehry, M. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2345 · Cited by 179
VanArsdale, T. L., VanArsdale, S. L., Force, W. R., Walter, B. N., Mosialos, G., Kieff, E., Reed, J. C., & Ware, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2460 · Cited by 175
Self-citationKaye, K. M., Izumi, K. M., Mosialos, G., & Kieff, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.675-683.1995 · Cited by 173
Self-citationMoorthy, R. K., & Thorley-Lawson, D. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1638-1646.1993 · Cited by 172
Miller, W. E., Mosialos, G., Kieff, E., & Raab-Traub, N. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.586-594.1997 · Cited by 167
Self-citationHammerschmidt, W., Sugden, B., & Baichwal, V. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2469-2475.1989 · Cited by 151
Baichwal, V. R., & Sugden, B. (1989) · PubMed · Cited by 85
Izumi, K. M., Kaye, K. M., & Kieff, E. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4369-4376.1994 · Cited by 71
Self-citationEpstein-Barr virus recombinants from overlapping cosmid fragments
Tomkinson, B. E., Robertson, E. S., Yalamanchili, R. R., Longnecker, R., & Kieff, E. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7298-7306.1993 · Cited by 68
Self-citationLiebowitz, D., Mannick, J. B., Takada, K., & Kieff, E. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4612-4616.1992 · Cited by 62
Self-citation(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80111-3 · Cited by 15
Cited by
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
Epstein–Barr virus in the pathogenesis of NPC
Raab-Traub, N. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x0200086x · Cited by 562
Walsh, M. C., Lee, J., & Choi, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12302 · Cited by 438
Metadata
- Authors
- Izumi, K. M., & Kieff, E. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-11-11
- Volume
- 94
- Issue
- 23
- Pages
- 12592-12597
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048905748
- Cited by
- 394
- References
- 41
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.